Card processing live for a CBD brand banks wouldn't take.

A CBD e-commerce brand selling EU-compliant products came to us with a frustrating problem. Their product was legal. Their lab reports were clean. Their THC levels were well under the regulatory threshold in every market they sold to. None of that mattered to banks and payment processors. The three letters C-B-D in the application triggered an automatic no.

The company had been selling through workarounds — bank transfers, manual invoicing, and a clunky checkout experience that was costing them customers on every order. They'd applied to banks and PSPs across multiple EU countries. All declined. The rejections weren't about compliance or risk assessment. They were about category policy. CBD sits on the restricted list at most acquiring banks, and that list doesn't distinguish between a compliant brand with lab-tested products and everything else in the category.

What they were dealing with

• Fully EU-compliant CBD products with third-party lab testing
• Bank account applications rejected across multiple EU countries
• Every PSP application declined on category classification alone
• Selling via bank transfer and manual invoicing — no card checkout
• High cart abandonment from customers who expected normal card payment
• Competitors with card processing were winning on checkout experience alone

The business was growing despite the checkout friction, which made the problem worse in a way. Every month of growth meant more revenue lost to cart abandonment. They were spending on marketing, driving traffic, and then losing a chunk of it at the payment step because asking someone to do a manual bank transfer for a €40 order is asking too much.

What we did

We connected them with PSPs that have CBD in their underwriting appetite. These are processors that have done the work to understand the regulatory landscape, know the difference between compliant and non-compliant product, and have acquiring bank relationships that support the category. They exist — they're just not the processors that show up on the first page of a Google search.

We packaged the application with everything the acquirer needs to say yes quickly: product catalog with THC certifications, lab reports, regulatory compliance documentation per target market, and a website audit confirming that product claims and marketing met acquirer guidelines.

• Identified PSPs with explicit CBD underwriting and acquiring bank support
• Packaged the application with lab reports, THC certifications, and compliance documentation
• Conducted website audit to ensure marketing met acquirer content requirements
• Onboarded Visa and Mastercard processing
• Integrated card checkout into their existing e-commerce platform

The website audit was important. Even PSPs that accept CBD will decline if the website makes health claims, shows non-compliant imagery, or markets the product in ways that acquiring banks flag. We reviewed every product page and checkout flow before submission.

The difference it made

The company now has Visa and Mastercard checkout like any normal e-commerce store. Customers add to cart, enter their card, and pay. No bank transfers. No manual invoicing. No friction. The checkout experience went from a competitive disadvantage to a non-issue.

Cart abandonment dropped. Average order value held steady, but the number of completed orders went up because fewer customers were walking away at payment. The marketing spend that was already driving traffic now converts at the rate it should have been converting all along.

What's running today

Card processing is live and stable. The PSP relationship is built on full category disclosure — there's no risk of a surprise shutdown because the acquirer knew exactly what the business sells from day one. As the company expands its product line or enters new EU markets, the acquiring setup supports it.

We continue to manage the PSP relationship. If they want to add local payment methods in specific markets or bring on a second processor for redundancy, the infrastructure is ready. The hard part — getting a CBD company through the door with a real acquirer — is done.